Early anti-VEGF treatment for hemorrhagic occlusive retinal vasculitis as a complication of cataract surgery

Abstract Background We report a case of hemorrhagic occlusive retinal vasculitis (HORV) after prophylactic intracameral vancomycin use during an uneventful cataract surgery treated with early anti-VEGF treatment. Case presentation A 51-year-old female underwent uneventful cataract surgery with proph...

Full description

Bibliographic Details
Main Authors: Konstantinos Andreanos, Petros Petrou, George Kymionis, Dimitrios Papaconstantinou, Ilias Georgalas
Format: Article
Language:English
Published: BMC 2017-12-01
Series:BMC Ophthalmology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12886-017-0632-y
Description
Summary:Abstract Background We report a case of hemorrhagic occlusive retinal vasculitis (HORV) after prophylactic intracameral vancomycin use during an uneventful cataract surgery treated with early anti-VEGF treatment. Case presentation A 51-year-old female underwent uneventful cataract surgery with prophylactic intracameral vancomycin during the procedure. On the seventh post-operative-day, she presented with sudden painful, visual loss. Fundus examination revealed peripheral hemorrhagic retinal vasculitis. She received anti-VEGF therapy to prevent further vision loss and retinal neovascularization due to extensive retinal ischemia. At the 6-month follow-up visit, visual acuity was 20/20 with no sign of neovascularization. Conclusions Postoperative HORV is a devastating condition that can occur after otherwise uncomplicated cataract surgery. The nature of this rare condition remains unknown. Early anti-VEGF administration seems to demonstrate favorable results.
ISSN:1471-2415